Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Open-label, Community-based, Cluster Randomised Controlled Trial to Evaluate the Efficacy, Cost-effectiveness, and Acceptability of Attractive Targeted Sugar Baits (ATSB) for Malaria Burden Reduction in Western Kenya

NCT05219565 is registered in ClinicalTrials.gov with Liverpool School of Tropical Medicine as lead sponsor.

NCT NCT05219565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05219565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Open-label, Community-based, Cluster Randomised Controlled Trial to Evaluate the Efficacy, Cost-effectiveness, and Acceptability of Attractive Targeted Sugar Baits (ATSB) for Malaria Burden Reduction in Western Kenya
Lead sponsor
Liverpool School of Tropical Medicine
Phase
Not applicable
Overall status
Completed
Start date
March 7, 2022
Completion date
April 24, 2024
Enrollment
2,962 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

malaria